Lirit Levi

Dr. Lirit Levi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DYDan Yaniv
Dan Yaniv
OZOfir Zavdy
Ofir Zavdy
ESEinav Sapir
Einav Sapir
LLLirit Levi
Lirit Levi
ESEthan Soudry
Ethan Soudry

6 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LLLirit Levi
Lirit Levi
EHElad Hikri
Elad Hikri
APAron Popovtzer
Aron Popovtzer
ADAvraham Dayan
Avraham Dayan
ALAmir Levi
Amir Levi
HSHagit Shoffel-Havakuk
Hagit Shoffel-Havakuk
Recent studies suggest that opioids have a role in the progression of HNSCC mediated by mu opioid receptors (MOR), however, the effects of their activation or blockage remains unclear. Expression of MOR-1 was explored in seven HNSCC cell lines using Western blotting (WB). XTT cell proliferation and cell migration assays were performed on four selected cell lines (Cal-33, FaDu, HSC-2, and HSC-3), treated with opiate receptor agonist (morphine), antagonist (naloxone), alone and combined with cisplatin. All four selected cell lines display an increased cell proliferation and upregulation of MOR-1 when exposed to morphine. Furthermore, morphine promotes cell migration, while naloxone inhibits it. The effects on cell signaling pathways were analyzed using WB, demonstrating morphine activation of AKT and S6, key proteins in the PI3K/AKT/mTOR axis. A significant synergistic cytotoxic effect between cisplatin and naloxone in all cell lines is observed. In vivo studies of nude mice harboring HSC3 tumor treated with naloxone demonstrate a decrease in tumor volume. The synergistic cytotoxic effect between cisplatin and naloxone is observed in the in vivo studies as well. Our findings suggest that opioids may increase HNSCC cell proliferation via the activation of the PI3K/Akt/mTOR signaling pathway. Moreover, MOR blockage may chemo-sensitize HNSCC to cisplatin.

13 July 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
LLLirit Levi
Lirit Levi
SHShany Havazelet
Shany Havazelet
YRYonatan Reuven
Yonatan Reuven
AEAiman Elmograbi
Aiman Elmograbi
SBSamih Badir
Samih Badir
ESEthan Soudry
Ethan Soudry

8 January 2025 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
LLLirit Levi
Lirit Levi
KYKenan Ye
Kenan Ye
MFMaxime Fieux
Maxime Fieux
ARAxel Renteria
Axel Renteria
SLSteven Lin
Steven Lin
MCMichael T. Chang
Michael T. Chang
Background: We developed and assessed the performance of a machine learning model (MLM) to identify, classify, and segment sinonasal masses based on endoscopic appearance.Methods: A convolutional neural network‐based model was constructed from nasal endoscopy images from patients evaluated at an otolaryngology center between 2013 and 2024. Images were classified into four groups: normal endoscopy, nasal polyps, benign, and malignant tumors. Polyps and tumors were confirmed with histopathological diagnosis. Images were annotated by an otolaryngologist and independently verified by two other otolaryngologists. We used high‐ and low‐quality images to mirror real‐world conditions. The models used for classification (EfficientNet‐B2) and segmentation (nnUNet) were trained, validated, and tested at an 8:1:1 ratio. The performance accuracy was averaged across a 10‐fold cross‐validation assessment. Segmentation accuracy was assessed via Dice similarity coefficients.Results: A total of 1242 images from 311 patients were used. The MLM was trained, validated, and tested on 663 normal, 276 polyps, 157 benign, and 146 malignant tumors images. Overall, the model performed at 84.1 ± 4.3% accuracy in the validation set and 80.4 ± 1.7% in the test set. The model correctly identified the presence of a sinonasal mass at 90.5 ± 1.2% accuracy rate. The MLM accuracy performance rates were 86.2 ± 1.0% for polyps and 84.1 ± 1.8% for tumors. Benign and malignant tumor subclassification achieved 87.8 ± 2.1% and 94.0 ± 2.4% accuracy, respectively. Segmentation accuracies for polyps were 72.3% and 72.8% for tumors.Conclusions: An MLM for nasal endoscopy images can perform with moderate to high accuracy in identifying, classifying, and segmenting sinonasal masses. Performance in future iterations may improve with larger and more diverse training datasets.

1 May 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
LLLirit Levi
Lirit Levi
LKLiora Kornreich
Liora Kornreich
OHOhad Hilly
Ohad Hilly
EREyal Raveh
Eyal Raveh
DGDror Gilony
Dror Gilony

1 July 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
YNYuval Nachalon
Yuval Nachalon
YRYael Reicher
Yael Reicher
UAUri Alkan
Uri Alkan
LLLirit Levi
Lirit Levi
GBGideon Bachar
Gideon Bachar
APAron Popovtzer
Aron Popovtzer